Topics

Companies Related to "Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction" [Most Relevant Company Matches] RSS

13:11 EST 17th November 2019 | BioPortfolio

Here are the most relevant search results for "Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction" found in our extensive corporate database of over 50,000 company records.

Showing "Ginkgo Biloba Antidepressant Induced Sexual Dysfunction" Companies 1–25 of 217

Relevant

Thrust Health, LLC

In a society fully exposed to the benefits of high-powered pharmaceutical solutions to sexual dysfunction, Thrust Health has developed the first-ever preventative care program and comprehensive wellness package designed to enhance sexual performance for both men and women – for use in the privacy of their home.


China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use ...

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare prod...


Adams Urology Clinic

The male menopause can also lead to stress, lower confidence and depression in men due to their sexual dysfunction. Therefore, proper measures and treatments are in desperate need.

NuMale Medical Center

NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation and low sex drive, utilizing a wide range of the most highly respected, FDA-approved treatments. Founded and led b...

Boston Medical Group

For over a decade, Boston Medical Group’s network of independent physicians has provided men with solutions to treat sexual health issues such as erectile dysfunction and premature ejaculation. The physicians provide therapies and treatment programs that can help men regain their sexual health and function, including those who are unable to take syste...

Ginkgo Bioworks

Ginkgo Bioworks is an organism design company that is building organisms to spec for customers across markets including nutrition, health and consumer goods. The company’s organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. The company was founded in 2008 by Tom Knight, a world-r...

Zonagen Incorporated

Zonagen Incorporated is a biopharmaceutical company engaged in the development of pharmaceutical products for the reproductive system, including sexual dysfunction, urology, contraception and infertility.

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

LIFESPAN labs

LIFESPAN labs is the manufacturer of men’s sexual health supplement, 112 Degrees. Based in Portland, Oregon, LIFESPAN labs is dedicated to providing high-quality, all-natural products that support male sexual health including sexual performance and male urogenital function. For more complete information about 112 Degrees and LIFESPAN labs, including t...

Jerry Cott, Ph.D

Jerry is a neuropsychopharmacologist specializing in clinical and preclinical psychotherapeutic drug development. Since obtaining his Ph.D. in pharmacology at the University of North Carolina in Chapel Hill, and a postdoctoral fellowship with Nobel Laureate, Arvid Carlsson, at the University of Göteborg, Sweden, he has had a variety of work experiences including: teaching medical school at the Un...

EuroPharma, Inc.

EuroPharma, Inc., maker of the Terry Naturally® brand, offers clinically proven and effective nutritional supplements that improve the health of America. Terry Lemerond, founder and president of EuroPharma, is well-known for innovation, and is credited as the first to introduce glucosamine sulfate and standardized Ginkgo biloba to the U.S. natural produ...

Sexual Recovery Institute

The Sexual Recovery Institute (SRI) is the leading outpatient recovery center for sexual addiction and intimacy disorders in the United States. Founded in 1995 by Robert Weiss, LCSW, CSAT-S, SRI offers intensive outpatient programs and outpatient therapy, along with services to professionals including workshops, seminars and program development.

VIVUS, Inc.

VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. QNEXA is also in phase 2 clinical development for the tr...

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc.

BioSante’s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its company, including licenses, business collaborations and other business combinations or transactions with other pharmaceutical and biotechnology companies. BioSante’s products ...

NexMed, Inc.

NexMed is the largest specialty CRO based in San Diego, CA and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models. The Company’s goal is to generate revenues from the growth of its Discovery Pre-clinical CRO business, while aggressively seeking to monetize its proprietary NexACT drug delivery ...

Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding number of consumers including health issues related to male and female sexual dysfunction, scar and stretch mark...

Easton Pharmaceuticals, Inc.

Toronto-based Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding number of consumers including health issues related to male and female sexual dysfunction, scar an...

NexMed

NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, arthritis, sexual disorders and more. NexMed offers large pharmaceutical companies the opportunity to incorporate NexACT® into their existing drugs, allowing these co...

Easton Pharmaceuticals Inc.

Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding number of consumers including health issues related to female and male sexual dysfunction, treatment of certain ...

EPIX Medical Incorporated

Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female sexual arousal dysfunction, atherosclerosis and myocardial perfusion. In addition to MS-325, EPIX's pipeline includes a new class of MR...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™ - all ...

Apricus Biosciences, Inc.

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. Future growth is expected to be driven primarily through out-licensing of this technology...

EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...


More From BioPortfolio on "Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction"

Quick Search

Corporate Database Quicklinks